Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models
- PMID: 20232046
- DOI: 10.1007/s00134-010-1824-6
Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models
Abstract
Purpose: Methods for estimating the excess mortality attributable to ventilator-associated pneumonia (VAP) should handle VAP as a time-dependent covariate, since the probability of experiencing VAP increases with the time on mechanical ventilation. VAP-attributable mortality (VAP-AM) varies with definitions, case-mix, causative microorganisms, and treatment adequacy. Our objectives here were to compare VAP-AM estimates obtained using a traditional cohort analysis, a multistate progressive disability model, and a matched-cohort analysis; and to compare VAP-AM estimates according to VAP characteristics.
Methods: We used data from 2,873 mechanically ventilated patients in the Outcomerea database. Among these patients from 12 intensive care units, 434 (15.1%) experienced VAP; of the remaining patients, 1,969 (68.5%) were discharged alive and 470 (16.4%) died. With the multistate model, VAP-AM was 8.1% (95% confidence interval [95%CI], 3.1-13.1%) for 120 days' complete observation, compared to 10.4% (5.6-24.5%) using a matched-cohort approach (2,769 patients) with matching on mechanical ventilation duration followed by conditional logistic regression. VAP-AM was higher in surgical patients and patients with intermediate (but not high) Simplified Acute Physiologic Score II values at ICU admission. VAP-AM was significantly influenced by time to VAP but not by resistance of causative microorganisms. Higher Logistic Organ Dysfunction score at VAP onset dramatically increased VAP-AM (to 31.9% in patients with scores above 7).
Conclusion: A multistate model that appropriately handled VAP as a time-dependent event produced lower VAP-AM values than conditional logistic regression. VAP-AM varied widely with case-mix. Disease severity at VAP onset markedly influenced VAP-AM; this may contribute to the variability of previous estimates.
Similar articles
-
Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis.Am J Respir Crit Care Med. 2011 Nov 15;184(10):1133-9. doi: 10.1164/rccm.201105-0867OC. Am J Respir Crit Care Med. 2011. PMID: 21852541
-
Ventilator-Associated Pneumonia due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality.Medicina (Kaunas). 2019 Feb 13;55(2):49. doi: 10.3390/medicina55020049. Medicina (Kaunas). 2019. PMID: 30781896 Free PMC article.
-
Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset.Intensive Care Med. 2007 Aug;33(8):1363-8. doi: 10.1007/s00134-007-0721-0. Epub 2007 Jun 9. Intensive Care Med. 2007. PMID: 17558495
-
Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.Cochrane Database Syst Rev. 2020 Dec 24;12(12):CD008367. doi: 10.1002/14651858.CD008367.pub4. Cochrane Database Syst Rev. 2020. PMID: 33368159 Free PMC article.
-
Multimodality respiratory physiotherapy reduces mortality but may not prevent ventilator-associated pneumonia or reduce length of stay in the intensive care unit: a systematic review.J Physiother. 2018 Oct;64(4):222-228. doi: 10.1016/j.jphys.2018.08.005. Epub 2018 Sep 13. J Physiother. 2018. PMID: 30220625
Cited by
-
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution.Antimicrob Agents Chemother. 2020 Sep 21;64(10):e02367-19. doi: 10.1128/AAC.02367-19. Print 2020 Sep 21. Antimicrob Agents Chemother. 2020. PMID: 32661000 Free PMC article.
-
A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes.Chest. 2016 Nov;150(5):1008-1014. doi: 10.1016/j.chest.2016.04.009. Epub 2016 Apr 19. Chest. 2016. PMID: 27102181 Free PMC article.
-
Recent progress in experimental and human disease-associated multi-species biofilms.Comput Struct Biotechnol J. 2019 Oct 25;17:1234-1244. doi: 10.1016/j.csbj.2019.09.010. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31921390 Free PMC article. Review.
-
The tracheal tube: gateway to ventilator-associated pneumonia.Crit Care. 2011;15(5):310. doi: 10.1186/cc10352. Epub 2011 Sep 29. Crit Care. 2011. PMID: 21996487 Free PMC article.
-
Unusually High Incidences of Staphylococcus aureus Infection within Studies of Ventilator Associated Pneumonia Prevention Using Topical Antibiotics: Benchmarking the Evidence Base.Microorganisms. 2018 Jan 4;6(1):2. doi: 10.3390/microorganisms6010002. Microorganisms. 2018. PMID: 29300363 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources